Last reviewed · How we verify
Maintenance of Healing Duodenal Ulcer
Approved treatments
- Carafate · Forest Labs Inc
- Carafate · Generic (originally Marion Merrell Dow)
- Pepcid · Generic (originally Yamanouchi/Merck)
Competitively blocks histamine H2 receptors on gastric parietal cells, reducing basal and stimulated acid secretion. - Prevacid · Vanderbilt University Medical Center
- Tagamet
- Axid Ar
- Prevacid · Generic (originally Takeda)
Irreversibly inhibits the gastric proton pump to suppress acid secretion.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Maintenance of Healing Duodenal Ulcer patent landscape — cliff calendar, originator estates, attackable patents
- Maintenance of Healing Duodenal Ulcer treatment landscape brief
- Maintenance of Healing Duodenal Ulcer treatment updates RSS
Frequently asked questions about Maintenance of Healing Duodenal Ulcer
What drugs treat Maintenance of Healing Duodenal Ulcer?
Tracked treatments include Carafate, Pepcid, Prevacid, Tagamet, Axid Ar.
What is the treatment for Maintenance of Healing Duodenal Ulcer?
Standard treatment for Maintenance of Healing Duodenal Ulcer includes Carafate, Pepcid, Prevacid, Tagamet, Axid Ar. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Maintenance of Healing Duodenal Ulcer patent cliff · Maintenance of Healing Duodenal Ulcer CI report
- Treatment: Carafate · Forest Labs Inc
- Treatment: Carafate · Generic (originally Marion Merrell Dow)
- Treatment: Pepcid · Generic (originally Yamanouchi/Merck)
- Treatment: Prevacid · Vanderbilt University Medical Center
- Treatment: Tagamet
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing